semaglutide for parkinson's Incretin and insulin signaling as novel therapeutic targets Alzheimer's and disease GLP-1 drug may help with

Diabetic Retinopathy In the SUSTAIN-6 trial, an increase in DRP complications, defined as a composite of need for retinal photocoagulation or treatment with intravitreal agents or vitreous hemorrhage or diabetes-related-blindness, was reported for semaglutide compared to placebo (hazard ratio 1.76

MB Core ingredients Berberine root extract is the most researched ingredient in the formula

Besides all that, a new study found a very concerning link between these drugs and thyroid cancer

2a, an effect which is almost the same as that of the SEMA-only treated group, as shown in Fig

Its a little bit shady, she says

Recent research suggests GLP-1 medications like Wegovy may unintentionally disrupt your circadian rhythm, the 24-hour biological cycle that determines when you feel alert or sleepy